The paper trail

Small print.
Wide open.

A clear path from a claim to the page it came from. Here’s the filing, the research, and how we read it.

The documentS–1Anthropic, PBC26 OCT 2026 · 421 PP.
01The original SEC filingThe authoritative source, in your browser.SEC · HTML 02Download the saved filingThe complete 421-page document, optimized for downloading.PDF · 46 MB 03Download the full researchFindings, customer examples, calculations, and source references.Markdown

Page by page

Go straight to the source.

Page references count physical pages in the saved PDF, starting at 1. The printed filing number is shown separately when available.

Enter a page from 1 to 421. No PDF download needed.

From the filing

PDF page 121

Printed filing page 110 · Extracted page text

View on the SEC
Read the page text
Table of Contents

A common stock continues to be listed on the Nasdaq Global Select Market, we will be required to comply with 
the  provision  that  our  NGC  be  comprised  entirely  of  independent  directors  within  the  applicable  transition 
period. 

We  operate  as  a  Delaware  public  benefit  corporation.  As  a  public  benefit  corporation,  we 
cannot provide any assurance that we will achieve our Company Purpose. 

As  a  PBC,  we  are  intended  to  produce  a  public  benefit  or  benefits  and  to  operate  in  a  responsible  and 
sustainable  manner,  balancing  our  stockholders’  pecuniary  interests,  the  best  interests  of  those  materially 
affected  by  our  conduct,  and  the  Company  Purpose  identified  in  our  amended  and  restated  certificate  of 
incorporation. We cannot assure you that we will achieve our Company Purpose or that the expected positive 
impact  from  being  a  PBC  will  be  realized,  which  could  adversely  affect  our  reputation,  business,  financial 
condition,  and  results  of  operations.  As  a  PBC,  we  are  required,  under  Section  366  of  the  Delaware  General 
Corporation  Law  (“DGCL”)  and  pursuant  to  our  amended  and  restated  bylaws,  to  disclose  to  stockholders  a 
report at least biennially on our overall performance in promoting the public benefit identified in our amended 
and restated certificate of incorporation and the best interests of those materially affected by our conduct and 
on our assessment of our success in achieving our Company Purpose and in promoting those interests. If we are 
not timely or are unable to provide this report, or if the report is not viewed favorably by parties doing business 
with  us,  regulators,  others  reviewing  our  credentials,  or  other  stakeholders,  including  holders  of  our  Class  A 
common stock, our reputation as a PBC may be adversely affected.

Our  focus  on  the  long-term  best  interests  of  our  company  as  a  PBC,  and  the  duty  of  our 
directors  to  balance  the  pecuniary  interests  of  our  stockholders,  the  best  interests  of  those 
stakeholders  materially  affected  by  our  conduct,  and  our  Company  Purpose,  may  conflict 
with short-, medium-, or long-term financial interests and business performance, which may 
negatively impact the value of our Class A common stock.

We  have  made,  and  may  in  the  future  make,  decisions  that  we  believe  balance  the  pecuniary  interests  of  our 
stockholders, the best interests of those materially affected by our conduct, and the Company Purpose set forth 
in  our  amended  and  restated  certificate  of  incorporation,  even  if  such  decisions  may  negatively  impact  the 
short-, medium-, or long-term performance of our business, financial condition, and results of operations or the 
short-,  medium-,  or  long-term  performance  of  our  Class  A  common  stock.  This  may  impact  the  value  of  our 
Class A common stock and make owning our Class A common stock less appealing to investors who are focused 
on returns. Our decisions and actions in pursuit of long-term success may not result in the long-term benefits 
we expect, which could adversely affect our business, financial condition, and results of operations, as well as 
the market price of our Class A common stock. Such decisions and actions may include changes to our models, 
platform, and applications; limitations on certain uses of our models, platform, and applications; moderating 
the  pace  of  the  development  of  our  models  for  safety-related  reasons;  adjustments  to  the  timing  of  new 
offerings;  changes  in  how  we  deliver  customer  support;  investments  in  our  relationships  with  partners  and 
employees; investments in and introductions of new models, platforms, and applications; investments in social 
impact  initiatives  consistent  with  our  public  benefit  objectives;  and  changes  in  our  approach  to  working  with 
local or national jurisdictions on laws and regulations governing our business.

Our policies, including those on usage, currently prohibit, or may be revised in the future to prohibit, certain 
usage or other actions, which may have adverse commercial consequences to us. For example, our usage policy 
prohibits the use of our models, platform, and applications to develop or operate fully autonomous weapons or 
to conduct mass surveillance, including mass domestic surveillance, and we have declined to permit such uses 
based on our Company Purpose, notwithstanding the revenue those or similar uses could generate. Maintaining 
these limitations has had, and may continue to have, adverse commercial and financial consequences. We have 
also  restricted  or  delayed  the  availability  of  certain  capabilities  for  safety  reasons.  For  example,  we  initially 
released our Mythos model only as a gated research preview through Project Glasswing rather than making it 
broadly  available  to  the  public.  Similarly,  we  have  chosen  not  to  develop  certain  commercially  attractive 
offerings, such as image and video generation models, in order to direct our compute toward our research and 
safety  priorities.  Our  public  advocacy,  and  the  decisions  we  make  to  moderate  the  pace  of  AI  development, 
delay or restrict the release of models or features, or forgo commercial opportunities for safety-related reasons, 
may not maximize stockholder value, could have a negative impact on the value of our Class A common stock, 
and could result in litigation. Each of these decisions reflects our directors’ balancing of the pecuniary interests 
of our stockholders, the best interests of those materially affected by our conduct, and the Company Purpose. 

110

Text is provided for reference. Check the original for tables, images, and exact formatting.

Find a section 16 starting points

Section links may begin before the exact paragraph cited in a finding. PDF numbers below use physical pages.

  1. Founders’ letterp. 3SEC
  2. Defined termsp. 12SEC
  3. Prospectus summaryp. 16SEC
  4. Risk factorsp. 38SEC
  5. Management’s discussion & analysisp. 144SEC
  6. Businessp. 190SEC
  7. Governancep. 254SEC
  8. Executive compensationp. 275SEC
  9. Related-person transactionsp. 293SEC
  10. Principal & selling stockholdersp. 299SEC
  11. Capital-stock rightsp. 303SEC
  12. Shares eligible for future salep. 318SEC
  13. Underwritingp. 327SEC
  14. Auditor change & expertsp. 345SEC
  15. Financial statements & notesp. 347SEC
  16. Part II & exhibit indexp. 413SEC

How this was made

Read in full.
Kept in context.

A snapshot of the filing dated , rather than a live record of later events.

3primary reviewers
421pages reviewed
43image instances checked

The review

Three primary reviewers read non-overlapping ranges of the complete main filing. All 43 embedded image instances were transcribed and visually reviewed, including the founders’ letter, charts, and customer case studies. Financial tables were also checked visually for dates, units, and column alignment.

A separate reviewer checked the draft’s calculations, accounting interpretations, and customer qualifications. An additional check covered the later merged findings. The result is 62 findings and 21 customer examples.

The boundary

Companion contracts and other exhibits named in the filing’s index are separate documents and were not independently reviewed. Customer outcomes, technical benchmarks, forecasts, and scientific priority claims remain attributed company or customer disclosures.

The numbers

Dollar figures are U.S. dollars. H1 means the six months ended June 30; Q2 means the three months ended June 30. The 2026 interim financial statements are unaudited. Our calculations show their inputs and are labeled separately from reported values.

Blank fields stay undisclosed. Figures with different periods, conditions, or potentially overlapping scopes are kept separate. An earlier tender price is not an IPO price.

What the evidence labels mean
Reported in filing
A company disclosure, with the period and accounting basis retained.
Company estimate / company claim
An estimate or assertion attributed to the company, with its uncertainty preserved.
Our calculation
A derived figure using cited inputs. It is not a separately reported company metric.
Customer example
A selected case study, with its measurement limits. It is not representative ROI.
Proposed / conditional
A status qualifier for an arrangement that is not yet effective or depends on stated conditions.

About updates. This edition is tied to the October 26, 2026 filing. Any later revision should identify its new source date and preserve the basis of earlier claims.

The footnotes are only the beginning.Explore the findings Read the story
The original, in context

Open the footnote.

A closer look at the filing

Anthropic · Form S-1PDF 1

Opening page 1…

Filed October 26, 2026. PDF is approximately 46 MB and opens only when requested. Section links may precede the exact cited paragraph.